Veterinary Injectable Drugs for Bovine Respiratory Diseases Treatment with Oxytetracycline and Flunixin Meglumine

Veterinary Injectable Drugs Oxytetracycline and Flunixin Meglumine Injection

Composition
Each ml contains:
Oxytetracycline...….…300mg
Flunixin meglumine....20mg

Indication
It has anti-inflammatory and anti-pyretic effect. For the treatment of bovine respiratory diseases associated with Mannheimia haemolytica, and organisms including Pasteurella spp.
Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas in vitro which are sensitive to oxytetracycline.

Dosage and Administration
For deep intramuscular injection to cattle.
The recommended dosage is 1ml per 10kg bodyweight (equivalent to 30mg/kg oxytetracycline and 2mg/kg flunixin meglumine) on a single occasion.
Maximum volume per injection site: 15ml. If concurrent treatment is administered, use a separate injection site.

Side Effects
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hyper sensitivity to the product.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not administer other NSAIDs concurrently or within 24hours of each other.
Concurrent use of potentially nephrotoxic drugs should beavoided. Do not exceed the stated dose or duration of treatment.

Withdrawal Time
Animals must not be slaughtered for human consumption during treatment.
Cattle may be slaughtered for human consumption only after 35 days from the last treatment.
Not for use in cattle producing milk for human consumption.

Storage and Expired Time
Tightly sealed and store below 25ºC, avoid direct sun lights.
2 years.

Packing
100ml